Resultados de la búsqueda 41-50 of 9631 for monoclonal antibody

1. Hematología - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. ... * Whether the body makes antibodies ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may ... Rituximab is a monoclonal antibody. It binds to a protein called CD20, which ...

5. Hematología - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... monoclonal antibody, and compare them with clinical outcomes. A Study to Explore if it is Possible to Successfully Obtain Optical Coherence Tomography (OCT) ...

7. Hematología - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may ... Rituximab is a monoclonal antibody. It binds to a protein called CD20, which ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...